TY  - JOUR
AU  - Peterfy, Charles
AU  - Emery, Paul
AU  - Tak, Paul P
AU  - Østergaard, Mikkel
AU  - DiCarlo, Julie
AU  - Otsa, Kati
AU  - Navarro Sarabia, Federico
AU  - Pavelka, Karel
AU  - Bagnard, Marie-Agnes
AU  - Gylvin, Lykke Hinsch
AU  - Bernasconi, Corrado
AU  - Gabriele, Annarita
PY  - 2014
DO  - 10.1136/annrheumdis-2014-206015
UR  - http://hdl.handle.net/10668/10049
T2  - Annals of the rheumatic diseases
AB  - To evaluate changes in structural damage and joint inflammation assessed by MRI following rituximab treatment in a Phase 3 study of patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) who were naive to biological therapy....
LA  - en
KW  - DMARDs (biologic)
KW  - Inflammation
KW  - Magnetic Resonance Imaging
KW  - Rheumatoid Arthritis
KW  - Adult
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - Cartilage, Articular
KW  - Disease Progression
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Radiography
KW  - Rituximab
KW  - Severity of Illness Index
KW  - Treatment Outcome
TI  - MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study.
TY  - research article
VL  - 75
ER  -